decisionhealth Newsletters, Part B News - 2018 Issue 12 (December)
Practices must add opioid review during Medicare’s AWV and IPPE encounters
Subscribe or sign in to view the full article.
Article Overview
This article summarizes updated CMS guidance for Medicare preventive visits and explains how opioid-use review fits into the documentation expectations for IPPE and AWV encounters. It is relevant for primary care and other practices that bill these services, as well as compliance and coding staff who need to understand the reporting elements discussed in the CMS MLN Matters update. The article covers the affected visit types, the timing of the guidance, and the broader documentation and compliance implications.
Why This Topic Matters
The guidance affects common Medicare preventive services and may influence documentation, audit risk, and claim acceptance. Practices that bill IPPE and AWV services need to understand the updated Medicare expectations and related compliance considerations.
Article Sections
-
Coding
Overview of the Medicare preventive visit types discussed in the article and the documentation focus of the CMS update.
-
Add opioid review immediately
Discussion of implementation concerns, practice setting differences, and broader compliance implications associated with the updated guidance.
What You Will Learn
- Which Medicare preventive visit types are affected by the updated guidance
- How the article frames opioid-use review within preventive visit documentation
- Why the update matters for billing, denial risk, and compliance
- Which types of practices may be most impacted by the documentation emphasis
Who Should Read This
- Medical coders
- Compliance staff
- Billing staff
- Primary care practices
- Preventive medicine providers
- Practice managers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com